Covid Vaccine: Panacea Biotec to manufacture Covid-19 vaccine jointly with government; know what it means for investors

Panacea Biotec will manufacture vaccines for coronavirus in partnership with the government. SARS-Cov-2, a dominant covid-19 virus, will be the target of the company's vaccine development. They will also work on developing a vaccine for the beta coronavirus.

Previously, the firm focused on contract manufacturing, but now it will work with the Indian government for developing vaccines for covid-19.  Stocks appear to be responding as a result of this. At this time, there is around a 4% increase in price.

Analyst Rakesh Bansal tells investors what it means to invest in this stock. According to the charts, below - 204 is good support while above - 222 is a resistance, said Bansal.

He went on to say that this stock has a history that does not favour investors. Because of the vaccine, the firm has constantly been in the headlines, and whenever the stock market rises, the retailer gets stuck. As a result, trading in response to this news is not a wise idea, he suggested. Even if someone still wants to invest in this stock, the market expert advises putting a stop loss for yourself.

Basically, the track record of the company is not so good and that is why there is no move for trading, he concluded.

For More Details Watch Full Video Here:

BREAKING NEWS |

भारत सरकार के साथ मिलकर #PanaceaBiotech कोरोना वैक्सीन बनाएगी
SARS-Cov-2 के लिए कोरोना वैक्सीन बनाएगी
बीटा कोरोना वायरस के लिए भी कोरोना वैक्सीन बनाएगी #Vaccine | #CovidVaccine pic.twitter.com/5oeMxFAWg8

— Zee Business (@ZeeBusiness) February 21, 2022